EFA
RPID icon

Evernest Financial Advisors’s Rapid Micro Biosystems RPID Stock Holding History

Evernest Financial Advisors’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Buy
432,510
+307,510
+246% +$1.13M 0.21% 72
2025
Q4 		$469K Sell
125,000
-75,234
-38% -$261K 0.1% 120
2025
Q3 		$669K Buy
200,234
+156,234
+355% +$494K 0.19% 98
2025
Q2 		$152K Sell
44,000
-87,265
-66% -$253K 0.05% 166
2025
Q1 		$347K Buy
+131,265
New +$299K 0.12% 121

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Evernest Financial Advisors's RPID Position: Q1 2026 in Review

Evernest Financial Advisors increased its Rapid Micro Biosystems (RPID) stake by 246% in Q1 2026, buying an estimated $1.13M and bringing the position to 432,510 shares worth $1.02M. The position accounts for 0.21% of the portfolio, ranked #72.

Evernest Financial Advisors first reported a position in RPID in Q1 2025 and has held it in 5 quarters since. 46 funds tracked by Wall St. Rank hold RPID as of Q1 2026.

  • Evernest Financial Advisors held 432,510 shares of Rapid Micro Biosystems worth $1.02M as of Q1 2026.
  • Evernest Financial Advisors bought 307,510 Rapid Micro Biosystems shares in Q1 2026, an estimated $1.13M.
  • Rapid Micro Biosystems made up 0.21% of Evernest Financial Advisors's portfolio in Q1 2026, its #72 holding.
  • Evernest Financial Advisors first reported a position in Rapid Micro Biosystems in Q1 2025 and has held it in 5 quarters since.
  • 46 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q1 2026.

Based on Evernest Financial Advisors's 13F filing for Q1 2026, filed 4 May 2026.